Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates

Krystal Biotech (KRYS) PT Raised to $206 at Citi

November 4, 2024 4:42 PM EST

Citi analyst Carly Kenselaar raised the price target on Krystal Biotech (NASDAQ: KRYS) to $206.00 (from $204.00) while maintaining a Neutral rating.

The analyst comments "Though Vyjuvek sales of $83.8M were in-line vs. Citi/consensus of $82.3M/$83.4M, key risks associated with our... More